Geneoscopy is committed to reinventing the treatment of gastrointestinal diseases. Their innovative techniques for non-invasive diagnosis and treatment includes technology for assistance in early-stage colon cancer detection. As a venture-backed startup based in Saint Louis, Missouri, Geneoscopy is walking through building technology and bringing it to the marketplace. This includes commercializing technology coming out of universities and schools of medicine. For Geneoscopy, this is specifically Washington University’s School of Medicine.

In this episode, I learned a lot from Chief Commercial Officer, Vince Wong, JD, MBA, who has worked through the various aspects it takes to fully bring a product to market. We discussed what they’ve already accomplished, where they currently are, and their soon launching 10,000 clinical participant study. In particular, I was excited to discuss what Vince termed “air” support and “ground” support for product rollout. I hope you enjoy it as much as I did.

Topics In This Episode

Series B funded company; in development product FDA break-through designation

Product manufacturing plans and differing operating models for inside and outside the United States

Current competitors and how Geneoscopy is superior

Marketing and positioning: healthcare insurers, healthcare providers and opinion leaders, patient advocacy groups, patient awareness

Cutting through marketplace noise

Partnering with and leveraging existing footprints

“Air” support and “ground” support for product rollout

How launching a new product is both similar and different in method

Potential direct-to-consumer futures

Decentralized targeting creates widened reach, expanded demographics

Contact Info

Website: geneoscopy.com 

Clinical study participation: colonscreeningstudy.com 

Email: [email protected] 

Geneoscopy (company) LinkedIn: linkedin.com/company/geneoscopy 

Vince Wong LinkedIn: linkedin.com/in/vince-wong-7254151 

Twitter

Facebook